Rebound Therapy on Ventilatory Functions in Down Syndrome
Effect of Rebound Therapy on Ventilatory Functions in Children With Down Syndrome. A Randomized Controlled Trial
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
The purpose of this study is to examine the effects of rebound therapy on ventilatory functions in children with Down Syndrome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 15, 2026
CompletedFirst Posted
Study publicly available on registry
February 20, 2026
CompletedStudy Start
First participant enrolled
February 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2026
CompletedFebruary 20, 2026
February 1, 2026
3 months
February 15, 2026
February 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Forced Vital Capacity (FVC)
Spirometry will be used to measure forced vital capacity (FVC). It is the maximum volume of gas that can be expired when the child exhales as forcefully and as rapidly as possible after a maximal inspiration to assess the overall ability to move air in and out of the lungs. It is expressed in liter/minute.
Up to 12 weeks
Forced Expiratory Volume in the First Second (FEV1)
Spirometry will be used to measure forced expiratory volume in the first second (FEV1). It is the volume of gas expired over a given time interval (the first second) from the beginning of the FVC maneuver that reflects airflow in the large airways. It is expressed in liter/minute.
Up to 12 weeks
Secondary Outcomes (2)
Chest Expansion
Up to 12 weeks
Functional Mobility
Up to 12 weeks
Study Arms (2)
Chest Physical Therapy Protocol
ACTIVE COMPARATORChildren with Down Syndrome will receive a chest physical therapy exercises
Rebound Therapy Protocol
EXPERIMENTALChildren with Down Syndrome will receive a chest physical therapy exercises in addition to rebound therapy using mini trampoline.
Interventions
The chest physical therapy protocol include respiratory exercises and incentive spirometer training.
The chest physical therapy protocol include respiratory exercises and incentive spirometer training + rebound therapy protocol using mini-trampoline training
Eligibility Criteria
You may qualify if:
- Children ages will be ranged from 9 to 13 years old.
- Mild and moderate mental retardation with IQ level between 50-70 based on Stanford-Binet intelligence scale.
- Functional hearing and vision.
- Independent standing and walking.
You may not qualify if:
- Symptomatic pain.
- Musculoskeletal problems or/ atlanto-axial instability.
- Rheumatic and congenital heart disease
- History of previous surgical operation
- Regular participation in any sport activities.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 15, 2026
First Posted
February 20, 2026
Study Start
February 22, 2026
Primary Completion
May 22, 2026
Study Completion
May 22, 2026
Last Updated
February 20, 2026
Record last verified: 2026-02